Investigations on Therapeutic Potential of Gabexate Mesilate in Animal Model of Rheumatoid Arthritis

Saxena, A.K., Jain, P.N. and Bhatnagar, S., 2018. The prevalence of chronic
48
pain among adults in India. Indian journal of palliative care, 24(4), p.472.
2) Castellanos, J.P., Woolley, C., Bruno, K.A., Zeidan, F., Halberstadt, A. and
Furnish, T., 2020. Chronic pain and psychedelics: a review and proposed
mechanism of action. Regional Anesthesia & Pain Medicine, 45(7), pp.486-494.
3) King, S., Chambers, C.T., Huguet, A., MacNevin, R.C., McGrath, P.J., Parker,
L. and MacDonald, A.J., 2011. The epidemiology of chronic pain in children and
adolescents revisited: a systematic review. Pain, 152(12), pp.2729-2738.
4) Nahin RL. Estimates of pain prevalence and severity in adults: United States,
2012. The journal of pain. 2015 Aug 1;16(8):769-80.
5) Nahin, R.L., 2015. Estimates of pain prevalence and severity in adults: United
States, 2012. The journal of pain, 16(8), pp.769-780.
6) Breivik, H., Borchgrevink, P.C., Allen, S.M., Rosseland, L.A., Romundstad, L.,
Breivik Hals, E.K., Kvarstein, G. and Stubhaug, A., 2008. Assessment of
pain. BJA: British Journal of Anaesthesia, 101(1), pp.17-24.
7) Dureja, G.P., Jain, P.N., Shetty, N., Mandal, S.P., Prabhoo, R., Joshi, M.,
Goswami, S., Natarajan, K.B., Iyer, R., Tanna, D.D. and Ghosh, P., 2014.
Prevalence of chronic pain, impact on daily life, and treatment practices in
India. Pain Practice, 14(2), pp.E51-E62.
8) Gatchel RJ, Turk DC, editors. Psychosocial factors in pain: Critical perspectives.
Guilford Press; 1999 Feb 12.
9) Verdugo, R.J., Matamala, J.M., Inui, K., Kakigi, R., Valls-Solé, J., Hansson, P.,
Nilsen, K.B., Lombardi, R., Lauria, G., Petropoulos, I.N. and Malik, R.A., 2022.
Review of techniques useful for the assessment of sensory small fiber neuropathies:
Report from an IFCN expert group. Clinical Neurophysiology.
10) Steeds, C.E., 2009. The anatomy and physiology of pain. Surgery
(Oxford), 27(12), pp.507-511.
11) Gallar, J., Pozo, M.A., Tuckett, R.P. and Belmonte, C., 1993. Response of
sensory units with unmyelinated fibres to mechanical, thermal and chemical
stimulation of the cat’s cornea. The Journal of Physiology, 468(1), pp.609-622.
12) Hunt, S.P. and Koltzenburg, M. eds., 2005. The neurobiology of
pain:(molecular and cellular neurobiology). Molecular and Cellular Neurobi.
13) Bautista, D.M., Siemens, J., Glazer, J.M., Tsuruda, P.R., Basbaum, A.I.,
Stucky, C.L., Jordt, S.E. and Julius, D., 2007. The menthol receptor TRPM8 is the
49
principal detector of environmental cold. Nature, 448(7150), pp.204-208.
14) Bessac, B.F. and Jordt, S.E., 2008. Breathtaking TRP channels: TRPA1 and
TRPV1 in airway chemosensation and reflex control. Physiology.
15) Tracey, W.D., 2017. Nociception. Current Biology, 27(4), pp.R129-R133.
16) Fitzgerald, M., 2005. The development of nociceptive circuits. Nature reviews
neuroscience, 6(7), pp.507-520.
17) Amaral, D.G., 2000. The anatomical organization of the central nervous
system. Principles of neural science, 4, pp.317-36.
18) Willis Jr, W.D. and Coggeshall, R.E., 2012. Sensory mechanisms of the spinal
cord: Volume 1 primary afferent neurons and the spinal dorsal horn. Springer
Science & Business Media.
19) Al-Chalabi, M., Reddy, V. and Gupta, S., 2018. Neuroanatomy, spinothalamic
tract.
20) Navarro-Orozco, D. and Bollu, P.C., 2021. Neuroanatomy, medial lemniscus
(reils band, reils ribbon). In StatPearls [Internet]. StatPearls Publishing.
21) Walker, A.E., 1940. The spinothalamic tract in man. Archives of Neurology &
Psychiatry, 43(2), pp.284-298.
22) Boggio, P.S., Zaghi, S. and Fregni, F., 2009. Modulation of emotions
associated with images of human pain using anodal transcranial direct current
stimulation (tDCS). Neuropsychologia, 47(1), pp.212-217.
23) Dixon, M.L., Thiruchselvam, R., Todd, R. and Christoff, K., 2017. Emotion
and the prefrontal cortex: An integrative review. Psychological bulletin, 143(10),
p.1033.
24) Younis, S., Hougaard, A., Noseda, R. and Ashina, M., 2019. Current
understanding of thalamic structure and function in migraine. Cephalalgia, 39(13),
pp.1675-1682.
25) Grouper, H., Löffler, M., Flor, H., Eisenberg, E. and Pud, D., 2022. Increased
functional connectivity between limbic brain areas in healthy individuals with high
versus low sensitivity to cold pain: A resting state fMRI study. PloS one, 17(4),
p.e0267170.
26) Martins, I. and Tavares, I., 2017. Reticular formation and pain: the past and the
future. Frontiers in neuroanatomy, 11, p.51.
27) Heinricher, M.M., Tavares, I., Leith, J.L. and Lumb, B.M., 2009. Descending
50
control of nociception: specificity, recruitment and plasticity. Brain research
reviews, 60(1), pp.214-225.
28) Bannister, K., Bee, L.A. and Dickenson, A.H., 2009. Preclinical and early
clinical investigations related to monoaminergic pain
modulation. Neurotherapeutics, 6(4), pp.703-712.
29) Llorca-Torralba, M., Borges, G., Neto, F., Mico, J.A. and Berrocoso, E., 2016.
Noradrenergic Locus Coeruleus pathways in pain modulation. Neuroscience, 338,
pp.93-113.
30) Millan, M.J., 2002. Descending control of pain. Progress in
neurobiology, 66(6), pp.355-474.
31) Melzack, R., 1996. Agreement on the value of theories of pain. In Pain
Forum (Vol. 2, No. 5, p. 150).
32) Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N.J. and Xu, J., 2018.
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic
therapies. Bone research, 6(1), p.15.
33) Lo, J., Chan, L. and Flynn, S., 2021. A systematic review of the incidence,
prevalence, costs, and activity and work limitations of amputation, osteoarthritis,
rheumatoid arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and
traumatic brain injury in the United States: a 2019 update. Archives of physical
medicine and rehabilitation, 102(1), pp.115-131.
34) De Cock, D., Van der Elst, K., Stouten, V., Peerboom, D., Joly, J., Westhovens,
R. and Verschueren, P., 2019. The perspective of patients with early rheumatoid
arthritis on the journey from symptom onset until referral to a
rheumatologist. Rheumatology Advances in Practice, 3(2), p.rkz035.
35) Feng, N. and Guo, F., 2020. Nanoparticle-siRNA: A potential strategy for
rheumatoid arthritis therapy?. Journal of Controlled Release, 325, pp.380-393.
36) Hasseli, R., Mueller-Ladner, U., Hoyer, B.F., Krause, A., Lorenz, H.M., Pfeil,
A., Richter, J., Schäfer, M., Schmeiser, T., Strangfeld, A. and Schulze-Koops, H.,
2021. Older age, comorbidity, glucocorticoid use and disease activity are risk
factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and
musculoskeletal diseases. Rmd Open, 7(1), p.e001464.
37) Taylor, P., Manger, B., Alvaro-Gracia, J., Johnstone, R., Gomez-Reino, J.,
Eberhardt, E., Wolfe, F., Schwartzman, S., Furfaro, N. and Kavanaugh, A., 2010.
51
Patient perceptions concerning pain management in the treatment of rheumatoid
arthritis. Journal of International Medical Research, 38(4), pp.1213-1224.
38) Bullock, J., Rizvi, S.A., Saleh, A.M., Ahmed, S.S., Do, D.P., Ansari, R.A. and
Ahmed, J., 2019. Rheumatoid arthritis: a brief overview of the treatment. Medical
Principles and Practice, 27(6), pp.501-507.
39) Yap, H.Y., Tee, S.Z.Y., Wong, M.M.T., Chow, S.K., Peh, S.C. and Teow, S.Y.,
2018. Pathogenic role of immune cells in rheumatoid arthritis: implications in
clinical treatment and biomarker development. Cells, 7(10), p.161.
40) Deane, K.D., Demoruelle, M.K., Kelmenson, L.B., Kuhn, K.A., Norris, J.M.
and Holers, V.M., 2017. Genetic and environmental risk factors for rheumatoid
arthritis. Best practice & research Clinical rheumatology, 31(1), pp.3-18.
41) Marinova?Mutafchieva, L., Taylor, P., Funa, K., Maini, R.N. and Zvaifler, N.J.,
2000. Mesenchymal cells expressing bone morphogenetic protein receptors are
present in the rheumatoid arthritis joint. Arthritis & Rheumatism: Official Journal
of the American College of Rheumatology, 43(9), pp.2046-2055.
42) Wechalekar, M.D. and Smith, M.D., 2014. Utility of arthroscopic guided
synovial biopsy in understanding synovial tissue pathology in health and disease
states. World journal of orthopedics, 5(5), p.566.
43) Reboul, P., Pelletier, J.P., Tardif, G., Cloutier, J.M. and Martel-Pelletier, J.,
1996. The new collagenase, collagenase-3, is expressed and synthesized by human
chondrocytes but not by synoviocytes. A role in osteoarthritis. The Journal of
clinical investigation, 97(9), pp.2011-2019.
44) Stockwell, R.A., 1979. Biology of cartilage cells (No. 7). CUP Archive.
45) Romas, E., Gillespie, M.T. and Martin, T.J., 2002. Involvement of receptor
activator of NF?B ligand and tumor necrosis factor-? in bone destruction in
rheumatoid arthritis. Bone, 30(2), pp.340-346.
46) Malarvizhi, E., 2019. A Prospective Open Labelled Phase-II Non Randomized
Clinical Trial Drug on Herbal Formulation of Nannari Ver Ooral Kudineer for the
treatment of Vali Azhal Keel Vayu (Rheumatoid Arthritis) (Doctoral dissertation,
Government Siddha Medical College, Palayamkottai).
47) Nigrovic, P.A. and Lee, D.M., 2007. Synovial mast cells: role in acute and
chronic arthritis. Immunological reviews, 217(1), pp.19-37.
48) Cuzzocrea, S., 2006. Role of nitric oxide and reactive oxygen species in
52
arthritis. Current pharmaceutical design, 12(27), pp.3551-3570.
49) Goldring, M.B., 2000. The role of the chondrocyte in osteoarthritis. Arthritis
& Rheumatism, 43(9), pp.1916-1926.
50) Vossenaar, E.R., Zendman, A.J., van Venrooij, W.J. and Pruijn, G.J., 2003.
PAD, a growing family of citrullinating enzymes: genes, features and involvement
in disease. Bioessays, 25(11), pp.1106-1118.
51) Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH. Anti-citrullinated
peptide antibody (ACPA) assays and their role in the diagnosis of rheumatoid
arthritis. Arthritis and rheumatism. 2009 Nov 11;61(11):1472.
52) Van Venrooij, W.J., Van Beers, J.J. and Pruijn, G.J., 2011. Anti-CCP
antibodies: the past, the present and the future. Nature Reviews
Rheumatology, 7(7), pp.391-398.
53) Lopez-Hoyos, M., Ruiz de Alegria, C., Blanco, R., Crespo, J., Pena, M.,
Rodriguez-Valverde, V. and Martinez-Taboada, V.M., 2004. Clinical utility of
anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid
arthritis and polymyalgia rheumatica. Rheumatology, 43(5), pp.655-657.
54) Linterman, M.A. and Vinuesa, C.G., 2010. T follicular helper cells during
immunity and tolerance. Progress in Molecular Biology and Translational
Science, 92, pp.207-248.
55) Baldanzi G. Immune checkpoint receptors signaling in T cells. International
Journal of Molecular Sciences. 2022 Mar 24;23(7):3529.
56) Kumar, S., Dhamija, B., Attrish, D., Sawant, V., Sengar, M., Thorat, J., Shet,
T., Jain, H. and Purwar, R., 2022. Genetic alterations and oxidative stress in T cell
lymphomas. Pharmacology & Therapeutics, p.108109.
57) Atitey, K. and Anchang, B., 2022. Mathematical Modeling of Proliferative
Immune Response Initiated by Interactions Between Classical Antigen-Presenting
Cells Under Joint Antagonistic IL-2 and IL-4 Signaling. Frontiers in Molecular
Biosciences, 9, p.7.
58) Choy, E., 2012. Understanding the dynamics: pathways involved in the
pathogenesis of rheumatoid arthritis. Rheumatology, 51(suppl_5), pp.v3-v11.
59) Scherer HU, Häupl T, Burmester GR. The etiology of rheumatoid arthritis.
Journal of autoimmunity. 2020 Jun 1;110:102400.
60) Folci, M., Ramponi, G., Solitano, V. and Brunetta, E., 2022. Serum ANCA as
53
disease biomarkers: clinical implications beyond vasculitis. Clinical Reviews in
Allergy & Immunology, 63(2), pp.107-12